FDA Approved: SPRIX — Supplemental Application (Zyla Life Sciences US LLC)

View source ↗

Summary

The FDA approved a supplemental application for SPRIX (ketorolac tromethamine) submitted by Zyla Life Sciences US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• SPRIX (ketorolac tromethamine)

Snippet

SUPPL AP for SPRIX (KETOROLAC TROMETHAMINE)